← Back to ABUS

Arbutus Biopharma Corporation - Common Stock financial statements

Annual and standalone quarterly facts filed by the company with the SEC. Monetary values are shown in USD millions; per-share values use USD.

Filed statements

USD; millions except EPSJun 2026Filed 12/08/2026Mar 2026Filed 12/08/2026Sep 2025Filed 13/11/2025Jun 2025Filed 12/08/2026Mar 2025Filed 12/08/2026Sep 2024Filed 13/11/2025Jun 2024Filed 13/11/2025Mar 2024Filed 13/11/2025
$1$179$0.5$11$1.8$1.3$1.7$1.5
−$5.1$170−$7.7$2.5−$25−$20−$20−$18
−$0.03$0.87−$0.04$0.01−$0.13−$0.10−$0.11−$0.10
197195192192191189188176

Trend

Revenue

Source: SEC EDGAR Company Facts. Values are normalized from issuer-filed US GAAP or IFRS XBRL facts. Missing cells stay missing; cumulative interim cash flows are not converted into estimated quarters.